i prefer the following topic - Integrating vericiguat into contemporary quadruple therapy: sequencing, patient selection, and deprescribing Rationale: Post-2021, SGLT2i and ARNI shifted HF care; how to prioritize, sequence, and monitor vericiguat in high-risk, hypotension-prone patients remains unsettled. Novelty: Few practical, decision-oriented algorithms exist for sequencing and de-escalation in polypharmacy, especially post-worsening HF. Angle: Propose a pragmatic algorithm based on ri - tlooto, The Most Powerful AcademicGPT

Excellent choice — that’s a very timely and practice-oriented review concept. Your selected topic “Integrating Vericiguat into Contemporary Quadruple Therapy for HFrEF: Sequencing, Patient Selection, - tlooto, AI-Powered Assistant for Academic and Research